Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
One versus two years of elastic compression stockings for prevention of post-thrombotic syndrome (OCTAVIA study): randomised controlled trial.
Mol GC, van de Ree MA, Klok FA, Tegelberg MJ, Sanders FB, Koppen S, de Weerdt O, Koster T, Hovens MM, Kaasjager HA, Brouwer RE, Kragten E, Schaar CG, Spiering W, Arnold WP, Biesma DH, Huisman MV. Mol GC, et al. Among authors: schaar cg. BMJ. 2016 May 31;353:i2691. doi: 10.1136/bmj.i2691. BMJ. 2016. PMID: 27245485 Free PMC article. Clinical Trial.
Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study.
van der Hulle T, Cheung WY, Kooij S, Beenen LFM, van Bemmel T, van Es J, Faber LM, Hazelaar GM, Heringhaus C, Hofstee H, Hovens MMC, Kaasjager KAH, van Klink RCJ, Kruip MJHA, Loeffen RF, Mairuhu ATA, Middeldorp S, Nijkeuter M, van der Pol LM, Schol-Gelok S, Ten Wolde M, Klok FA, Huisman MV; YEARS study group. van der Hulle T, et al. Lancet. 2017 Jul 15;390(10091):289-297. doi: 10.1016/S0140-6736(17)30885-1. Epub 2017 May 23. Lancet. 2017. PMID: 28549662 Clinical Trial.
No added value of the age-adjusted D-dimer cut-off to the YEARS algorithm in patients with suspected pulmonary embolism.
van der Pol LM, van der Hulle T, Cheung YW, Mairuhu ATA, Schaar CG, Faber LM, Ten Wolde M, Hofstee HMA, Hovens MMC, Nijkeuter M, van Klink RCJ, Kruip MJHA, Middeldorp S, Huisman MV, Klok FA. van der Pol LM, et al. Among authors: schaar cg. J Thromb Haemost. 2017 Dec;15(12):2317-2324. doi: 10.1111/jth.13852. Epub 2017 Oct 24. J Thromb Haemost. 2017. PMID: 28941051 Free article.
Elastic compression stockings one year after DVT diagnosis: Who might discontinue?
Mol GC, Dronkers CEA, van de Ree MA, van der Pas SL, Tegelberg-Stassen MJAM, Sanders FBM, Koppen S, de Weerdt O, Koster T, Hovens MMC, Kaasjager HAH, Brouwer RE, Kragten E, Schaar CG, Spiering W, Arnold WP, Huisman MV, Klok FA. Mol GC, et al. Among authors: schaar cg. Thromb Res. 2019 Jan;173:35-41. doi: 10.1016/j.thromres.2018.11.002. Epub 2018 Nov 7. Thromb Res. 2019. PMID: 30468951
Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial.
van de Loosdrecht AA, Cremers EMP, Alhan C, Duetz C, In 't Hout FEM, Visser-Wisselaar HA, Chitu DA, Verbrugge A, Cunha SM, Ossenkoppele GJ, Janssen JJWM, Klein SK, Vellenga E, Huls GA, Muus P, Langemeijer SMC, de Greef GE, Te Boekhorst PAW, Raaijmakers MHG, van Marwijk Kooy M, Legdeur MC, Wegman JJ, Deenik W, de Weerdt O, van Maanen-Lamme TM, Jobse P, van Kampen RJW, Beeker A, Wijermans PW, Biemond BJ, Tanis BC, van Esser JWJ, Schaar CG, Noordzij-Nooteboom HS, Jacobs EMG, de Graaf AO, Jongen-Lavrencic M, Stevens-Kroef MJPL, Westers TM, Jansen JH. van de Loosdrecht AA, et al. Among authors: schaar cg. Leukemia. 2024 Apr;38(4):840-850. doi: 10.1038/s41375-024-02161-6. Epub 2024 Jan 31. Leukemia. 2024. PMID: 38297135 Free PMC article. Clinical Trial.
Black and blue . . . and unconscious.
van Onna M, van Bemmel T, van Wensen E, Schaar C, Slis H, Spronk PE. van Onna M, et al. BMJ. 2009 Jul 22;339:b2864. doi: 10.1136/bmj.b2864. BMJ. 2009. PMID: 19625351 No abstract available.
Role of eHealth application Oncokompas in supporting self-management of symptoms and health-related quality of life in cancer survivors: a randomised, controlled trial.
van der Hout A, van Uden-Kraan CF, Holtmaat K, Jansen F, Lissenberg-Witte BI, Nieuwenhuijzen GAP, Hardillo JA, Baatenburg de Jong RJ, Tiren-Verbeet NL, Sommeijer DW, de Heer K, Schaar CG, Sedee RE, Bosscha K, van den Brekel MWM, Petersen JF, Westerman M, Honings J, Takes RP, Houtenbos I, van den Broek WT, de Bree R, Jansen P, Eerenstein SEJ, Leemans CR, Zijlstra JM, Cuijpers P, van de Poll-Franse LV, Verdonck-de Leeuw IM. van der Hout A, et al. Among authors: schaar cg. Lancet Oncol. 2020 Jan;21(1):80-94. doi: 10.1016/S1470-2045(19)30675-8. Epub 2019 Dec 11. Lancet Oncol. 2020. PMID: 31838009 Clinical Trial.
Interferon-alpha as maintenance therapy in patients with multiple myeloma.
Schaar CG, Kluin-Nelemans HC, Te Marvelde C, le Cessie S, Breed WP, Fibbe WE, van Deijk WA, Fickers MM, Roozendaal KJ, Wijermans PW; Dutch-Belgian Hemato-Oncology Cooperative Group HOVON. Schaar CG, et al. Ann Oncol. 2005 Apr;16(4):634-9. doi: 10.1093/annonc/mdi125. Epub 2005 Mar 1. Ann Oncol. 2005. PMID: 15741226 Free article. Clinical Trial.
37 results